Kits Eyecare Ltd.
KTYCF
$10.13
-$0.06-0.59%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 14.80% | 27.29% | 20.70% | 23.91% | 29.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.80% | 27.29% | 20.70% | 23.91% | 29.54% |
| Cost of Revenue | 11.92% | 18.83% | 23.20% | 20.78% | 22.75% |
| Gross Profit | 19.86% | 41.86% | 16.30% | 30.28% | 43.47% |
| SG&A Expenses | 24.18% | 45.14% | 18.83% | 22.72% | 35.55% |
| Depreciation & Amortization | -4.80% | -16.07% | -33.21% | 9.79% | -0.19% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.03% | 27.21% | 21.47% | 21.33% | 26.70% |
| Operating Income | -29.83% | 28.59% | 5.19% | 145.85% | 615.18% |
| Income Before Tax | 515.62% | 32.06% | -83.96% | 919.23% | -222.75% |
| Income Tax Expenses | 199.33% | 43.24% | -66.40% | 457.54% | -2.05% |
| Earnings from Continuing Operations | 304.39% | 27.16% | -90.30% | 1,352.79% | -466.93% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 304.39% | 27.16% | -90.30% | 1,352.79% | -466.93% |
| EBIT | -29.83% | 28.59% | 5.19% | 145.85% | 615.18% |
| EBITDA | -23.56% | 20.00% | -2.05% | 85.68% | 145.90% |
| EPS Basic | 292.36% | 20.23% | -90.45% | 1,312.90% | -465.12% |
| Normalized Basic EPS | 491.30% | 25.08% | -54.37% | 905.41% | -221.05% |
| EPS Diluted | 279.62% | 21.26% | -89.63% | 1,403.45% | -465.12% |
| Normalized Diluted EPS | 488.41% | 31.31% | -53.27% | 900.00% | -230.19% |
| Average Basic Shares Outstanding | 6.09% | 5.74% | 1.94% | 1.81% | 1.75% |
| Average Diluted Shares Outstanding | 7.08% | 0.48% | -0.33% | 0.86% | -4.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |